Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:settlement
|
| gptkbp:announced |
2019
|
| gptkbp:approvedBy |
gptkb:U.S._Bankruptcy_Court
|
| gptkbp:containsSettlement |
$8 billion
|
| gptkbp:finalized |
2021
|
| gptkbp:includes |
Sackler family financial contribution
creation of public benefit company dissolution of Purdue Pharma |
| gptkbp:involves |
gptkb:OxyContin
|
| gptkbp:involvesBankruptcy |
true
|
| gptkbp:involvesCivilClaims |
true
|
| gptkbp:involvesCriminalCharges |
true
|
| gptkbp:objectedBy |
some state attorneys general
|
| gptkbp:purpose |
resolve opioid litigation
|
| gptkbp:relatedTo |
gptkb:Sackler_family
gptkb:Purdue_Pharma opioid epidemic |
| gptkbp:subjectOf |
public controversy
Supreme Court review |
| gptkbp:bfsParent |
gptkb:OxyContin
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Purdue Pharma settlement
|